← All stocks

Outlook Therapeutics, Inc.

OTLK Net buying
CIK 0001649989 #4052 in the set updated 17 Sep 2026
Bought (12 mo)
$7.87M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$7.87M
+$7.87M against sales at will

By person

7 insiders · 10 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Sukhtian Ghiath M.
Director
$7.50M (2)
+$7.50M
24,617,320
$24.37M
+165.7%
HILZINGER KURT J
Director
$176.52K (1)
+$176.52K
423,655
$419.42K
+1,691%
Sukhtian Faisal Ghiath
Director
$150.00K (2)
+$150.00K
220,972
$218.76K
+6,399%
Haddadin Yezan Munther
Director
$39.11K (2)
+$39.11K
66,167
$65.51K
+1,989%
THURMAN RANDY H
Director
$2.15K (1)
+$2.15K
5,593
$5.54K
+843.2%
Jahr Robert Charles
Chief Executive Officer
(1)
$0.00
151,515
$150.00K
KENYON LAWRENCE A
Chief Financial Officer
(1)
$0.00
106,956
$105.89K
+11,206%

No percentages here. This company's share count has moved by a factor of 9.8 over the window, from 24,905,635 to 243,447,554 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 21
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 2
Shares from compensation/vesting 0
History held since 14 Nov 2016